• RON L January 1, 2010 at 3:22 pm

    Whilst 1 billion doses of of the atypical H1N1 influenza vaccine may have been ordered, approximately 50 percent (500 million doses) will be surplus… who will end up paying for that?

  • janevm January 4, 2010 at 5:16 am

    France coughed up $1.25 billion to Sanofi-Pasteur, which is under the umbrella of Sanofi-Aventis, GlaxoSmithKline, Novartis and Baxter International, and now has a massive surplus that the French government is attempting to sell to other countries.

  • ben s January 4, 2010 at 8:36 am

    $40 billion dollars in revenue by 2012 sounds like a lot of incentive to hide adverse reactions such as ProQuad's deaths reported to VAERS, Merck themselves reported two of them in November 2008. (VAERS ID 331196 & 331194)

  • janevm January 4, 2010 at 9:03 am

    good point. Given that amount, personal injury and wrongful death suits are like chump change.

  • Leave a Reply


Find us on